Vitaspring Biomedical annual total assets
2017
2018
2020
2021
2022
2023
2024
2025
2026
Vitaspring Biomedical Total Assets Growth & History (VSBC)
Vitaspring Biomedical's total assets was $14,676 for fiscal 2026.
View full Vitaspring Biomedical company overviewVitaspring Biomedical annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-01-31 | $14,676 | $298 | +2.07% |
| 2025 | 2025-01-31 | $14,378 | −$122,964 | −89.53% |
| 2024 | 2024-01-31 | $137,342 | −$628,606 | −82.07% |
| 2023 | 2023-01-31 | $765,948 | −$2.8M | −78.75% |
| 2022 | 2022-01-31 | $3.6M | $3.4M | +1802.91% |
| 2021 | 2021-01-31 | $189,398 | $189,398 | — |
| 2020 | 2020-01-31 | $0 | — | — |
| 2018 | 2018-01-31 | $23,908 | $14,798 | +162.44% |
| 2017 | 2017-01-31 | $9,110 | — | — |
Vitaspring Biomedical quarterly total assets
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-04-30 | $11,432 | −$480 | −4.03% |
| Q4 2026 | 2026-01-31 | $14,676 | $298 | +2.07% |
| Q3 2026 | 2025-10-31 | $16,465 | — | — |
| Q2 2026 | 2025-07-31 | $17,020 | — | — |
| Q1 2026 | 2025-04-30 | $11,912 | — | — |
| Q4 2025 | 2025-01-31 | $14,378 | — | — |
| Q4 2023 | 2023-01-31 | $765,948 | −$2.8M | −78.75% |
| Q3 2023 | 2022-10-31 | $2.4M | $1.3M | +113.49% |
| Q2 2023 | 2022-07-31 | $2.6M | $1.9M | +269.52% |
| Q1 2023 | 2022-04-30 | $2.7M | $2.2M | +485.59% |
| Q4 2022 | 2022-01-31 | $3.6M | $3.4M | +1802.91% |
| Q3 2022 | 2021-10-31 | $1.1M | $1.1M | +157092.72% |
| Q2 2022 | 2021-07-31 | $699,472 | $668,494 | +2157.96% |
| Q1 2022 | 2021-04-30 | $460,509 | $459,616 | +51468.76% |
| Q4 2021 | 2021-01-31 | $189,398 | $189,398 | — |
| Q3 2021 | 2020-10-31 | $728 | — | — |
| Q2 2021 | 2020-07-31 | $30,978 | — | — |
| Q1 2021 | 2020-04-30 | $893 | — | — |
| Q4 2020 | 2020-01-31 | $0 | — | — |
| Q1 2019 | 2018-04-30 | $14,077 | −$877 | −5.86% |
| Q4 2018 | 2018-01-31 | $23,908 | $14,798 | +162.44% |
| Q3 2018 | 2017-10-31 | $9,044 | — | — |
| Q2 2018 | 2017-07-31 | $10,412 | — | — |
| Q1 2018 | 2017-04-30 | $14,954 | — | — |
| Q4 2017 | 2017-01-31 | $9,110 | — | — |
Vitaspring Biomedical total assets trends
Over the last five fiscal years, Vitaspring Biomedical's total assets decreased from $189,398 to $14,676, a change of −$174,722. The latest reported quarter, Q1 2027, shows $11,432.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vitaspring Biomedical source filings ↗